Discover how CRP, IL-6, and procalcitonin biomarkers are transforming infection detection in pediatric cancer patients with weakened immune systems.
Research on BNT162b2 mRNA COVID-19 vaccine effectiveness in pediatric cancer patients reveals crucial insights for protecting immunocompromised children.